Journal of Benefit-Cost Analysis

Papers
(The TQCC of Journal of Benefit-Cost Analysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries24
Valuing COVID-19 Morbidity Risk Reductions13
Achieving Maternal and Neonatal Mortality Development Goals Effectively: A Cost-Benefit Analysis11
A Tale of the Tails: The Value of a Statistical Life at the Tails of the Age Distribution9
BCA volume 13 issue 3 Cover and Back matter8
Dynamic Versus Static Modeling of Mortality-Related Benefits of PM2.5 Reductions in the USA and Chile: 1990 to 20508
The Net Benefits and Residual Cost from U.S. Border Management of the Initially Inadmissible7
A Benefit–Cost Analysis of Tulsa Pre-K, Based on Effects on High-School Graduation and College Attendance6
Assessing Risk, Effectiveness, and Benefits in Transportation Regulation5
The Weak Spot of Infrastructure BCA: Cost Overruns in Seven Road and Railway Construction Projects5
The Investment Case for Land Tenure Security in Sub-Saharan Africa: A Cost–Benefit Analysis4
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation4
Citizen Preferences and BCA: A Model of Willingness-to-Pay behind a Veil of Ignorance3
Funding a Just Transition Away from Coal in the U.S. Considering Avoided Damage from Air Pollution3
Early Education and Adult Health: Age 37 Impacts and Economic Benefits of the Child-Parent Center Preschool Program3
Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio3
Distribution and Disputation: Net Benefits, Equity, and Public Decision-Making3
The Global Burden of the COVID-19 Pandemic: Comparing Benefit–Cost Analysis and Social Welfare Analysis3
An Equity Blindspot: The Incidence of Regulatory Costs3
Prospective Evaluation of Health Communication Effects on Market Outcomes3
Benefit-Cost Ratios of Continuing Routine Immunization During the COVID-19 Pandemic in Africa3
Estimated Values of Avoiding Cancer Risks by Cancer Site and Population3
Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model – CORRIGENDUM3
Differences by Race and Ethnicity in Title IX’s Effect on Women’s Health2
BCA volume 13 issue 2 Cover and Front matter2
Valuing a Reduction in the Risk and Severity of Asthma: A Large Scale Multi-Country Stated Preference Approach2
Is California’s Electric Vehicle Rebate Regressive? A Distributional Analysis2
Renewable Energy Support Through Feed-in Tariffs: A Retrospective Stakeholder Analysis2
BCA volume 14 issue 2 Cover and Front matter2
Why Office of Management and Budget’s (OMB) Social Welfare Function Is Not Society’s Social Welfare Function2
“We Test”: An Imagined Regulatory Future2
All Cancers Are not Created Equal: How Do Survival Prospects Affect the Willingness to Pay to Avoid Cancer?2
One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond2
The Welfare Cost of Beijing’s Lottery Policy: Evidence from a Contingent Valuation Survey2
0.020915985107422